4.5 Article

Myosin II regulates the shape of three-dimensional intestinal epithelial cysts

期刊

JOURNAL OF CELL SCIENCE
卷 121, 期 11, 页码 1803-1814

出版社

COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.015842

关键词

actin polymerization; phospholipase C; ADF/cofilin; microtubules; protrusions; morphogenesis; tubulogenesis; Matrigel

资金

  1. NIDDK NIH HHS [DK 064399, DK 55679, DK 59888, DK 61379, DK 72564] Funding Source: Medline

向作者/读者索取更多资源

The development of luminal organs begins with the formation of spherical cysts composed of a single layer of epithelial cells. Using a model three-dimensional cell culture, this study examines the role of a cytoskeletal motor, myosin II, in cyst formation. Caco-2 and SK-CO15 intestinal epithelial cells were embedded into Matrigel, and myosin II was inhibited by blebbistatin or siRNA-mediated knockdown. Whereas control cells formed spherical cysts with a smooth surface, inhibition of myosin II induced the outgrowth of F-actin-rich surface protrusions. The development of these protrusions was abrogated after inhibition of F-actin polymerization or of phospholipase C (PLC) activity, as well as after overexpression of a dominant-negative ADF/cofilin. Surface protrusions were enriched in microtubules and their formation was prevented by microtubule depolymerization. Myosin II inhibition caused a loss of peripheral F-actin bundles and a submembranous extension of cortical microtubules. Our findings suggest that inhibition of myosin II eliminates the cortical F-actin barrier, allowing microtubules to reach and activate PLC at the plasma membrane. PLC-dependent stimulation of ADF/cofilin creates actin-filament barbed ends and promotes the outgrowth of F-actin-rich protrusions. We conclude that myosin II regulates the spherical shape of epithelial cysts by controlling actin polymerization at the cyst surface.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth

Sri HariKrishna Vellanki, Rodrigo G. B. Cruz, Hanne Jahns, Lance Hudson, Giovanni Sette, Adriana Eramo, Ann M. Hopkins

CANCER LETTERS (2019)

Article Oncology

Antibiotic Tetrocarcin-A Down-regulates JAM-A, IAPs and Induces Apoptosis in Triple-negative Breast Cancer Models

Sri Harikrishna Vellanki, Rodrigo G. B. Cruz, Cathy E. Richards, Yvonne E. Smith, Lance Hudson, Hanne Jahns, Ann M. Hopkins

ANTICANCER RESEARCH (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Apical periurethral transition zone lesions: MRI and histology findings

Sena Tuncer, Sherif Mehralivand, Stephanie A. Harmon, Thomas Sanford, G. Thomas Brown, Lindsay S. Rowe, Maria J. Merino, Bradford J. Wood, Peter A. Pinto, Peter L. Choyke, Baris Turkbey

ABDOMINAL RADIOLOGY (2020)

Article Medicine, General & Internal

ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis

Sara Charmsaz, Ben Doherty, Sinead Cocchiglia, Damir Vareslija, Attilio Marino, Nicola Cosgrove, Ricardo Marques, Nolan Priedigkeit, Siobhan Purcell, Fiona Bane, Jarlath Bolger, Christopher Byrne, Philip J. O'Halloran, Francesca Brett, Katherine Sheehan, Kieran Brennan, Ann M. Hopkins, Stephen Keelan, Petra Jagust, Stephen Madden, Chiara Martinelli, Matteo Battaglini, Steffi Oesterreich, Adrian V. Lee, Gianni Ciofani, Arnold D. K. Hill, Leonie S. Young

BMC MEDICINE (2020)

Article Oncology

Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1

Rodrigo G. B. Cruz, Stephen F. Madden, Cathy E. Richards, Sri HariKrishna Vellanki, Hanne Jahns, Lance Hudson, Joanna Fay, Naoimh O'Farrell, Katherine Sheehan, Karin Jirstrom, Kieran Brennan, Ann M. Hopkins

Summary: The study reveals that JAM-A regulates HER3 expression levels through the pathway involving beta-catenin and FOXA1, thereby reducing HER3-dependent tumorigenic signaling. This discovery may serve as a novel drug target for overcoming resistance to HER2-targeted therapies in breast cancer.

CANCERS (2021)

Article Oncology

Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers

Cathy E. Richards, Katherine M. Sheehan, Elaine W. Kay, Charlotta Hedner, David Borg, Joanna Fay, Anthony O'Grady, Arnold D. K. Hill, Karin Jirstrom, Ann M. Hopkins

Summary: High levels of Junctional Adhesion Molecule-A (JAM-A) protein have been associated with aggressive disease in various cancers, particularly in breast cancer patients overexpressing HER2. The study aimed to investigate the link between JAM-A and HER2 levels in gastro-esophageal (GE) cancers, revealing a significant correlation when accounting for intra-tumoral heterogeneity. This highlights the importance of considering heterogeneity in cancer biomarker studies for the benefit of patient treatment.

CANCERS (2021)

Article Cell Biology

Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation

Viktorija Juric, Lance Hudson, Joanna Fay, Cathy E. Richards, Hanne Jahns, Maite Verreault, Franck Bielle, Ahmed Idbaih, Martine L. M. Lamfers, Ann M. Hopkins, Markus Rehm, Brona M. Murphy

Summary: The activation of CDKs contributes to the uncontrolled proliferation of tumor cells, such as in the case of GBM. In this study, two CDK inhibitors, CYC065 and THZ1, showed promising therapeutic efficacy in GBM patient-derived cell lines, suppressing invasion and inducing cell death. These novel CKIs have the potential to be further investigated for clinical applications in the treatment of GBM.

CELL DEATH & DISEASE (2021)

Article Cell Biology

A Transcriptional Link between HER2, JAM-A and FOXA1 in Breast Cancer

Rodrigo G. B. Cruz, Stephen F. Madden, Kieran Brennan, Ann M. Hopkins

Summary: JAM-A transcriptionally regulates the expression of HER2 via FOXA1, and is associated with survival outcomes in patients with HER2-positive breast or gastric tumors.
Article Biochemistry & Molecular Biology

C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency

Laura T. Fee, Debananda Gogoi, Michael E. O'Brien, Emer McHugh, Michelle Casey, Ciara Gough, Mark Murphy, Ann M. Hopkins, Tomas P. Carroll, Noel G. McElvaney, Emer P. Reeves

Summary: Alpha-1 antitrypsin deficiency (AATD) is associated with increased risk of emphysema, COPD, vasculitis, and impaired wound healing. Dysregulated complement activation in AATD leads to elevated levels of C3d, which triggers degranulation of neutrophils and inhibits endothelial cell migration and wound healing. This study highlights potential implications for AATD-related vasculitis.

BIOMEDICINES (2021)

Article Oncology

Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression

Yvonne E. Smith, Guannan Wang, Ciara L. Flynn, Stephen F. Madden, Owen MacEneaney, Rodrigo G. B. Cruz, Cathy E. Richards, Hanne Jahns, Marian Brennan, Mattia Cremona, Bryan T. Hennessy, Katherine Sheehan, Alexander Casucci, Faizah A. Sani, Lance Hudson, Joanna Fay, Sri H. Vellanki, Siobhan O'Flaherty, Marc Devocelle, Arnold D. K. Hill, Kieran Brennan, Saraswati Sukumar, Ann M. Hopkins

Summary: Specific drug targets for breast ductal carcinoma in situ (DCIS) are difficult to determine, but this study suggests that JAM-A, a cell surface protein, could be a potential therapeutic target in DCIS patients. The study found that JAM-A is upregulated in DCIS patient tissues and a novel JAM-A-binding peptide inhibitor showed efficacy in inhibiting tumor growth in in vivo models. This finding provides valuable insights for the development of novel treatments for DCIS patients.

CANCERS (2022)

Article Pathology

Deep Domain Adversarial Learning for Species- Agnostic Classification of Histologic Subtypes of Osteosarcoma

Sushant Patkar, Jessica Beck, Stephanie Harmon, Christina Mazcko, Baris Turkbey, Peter Choyke, G. Thomas Brown, Amy LeBlanc

Summary: A convolutional neural network was trained to classify histologic patterns of osteosarcomas in humans using data from canine osteosarcomas. The trained model achieved good results and was able to identify distinct clinical responses in canine osteosarcomas.

AMERICAN JOURNAL OF PATHOLOGY (2023)

Article Oncology

Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

David Milewski, Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle, Marc Ladanyi, Erin R. Rudzinski, Hyoyoung Choo-Wosoba, Donald A. Barkauskas, Tammy Lo, David Hall, Corinne M. Linardic, Jun S. Wei, Hsien-Chao Chou, Stephen X. Skapek, Rajkumar Venkatramani, Peter K. Bode, Seth M. Steinberg, George Zaki, Igor B. Kuznetsov, Douglas S. Hawkins, Jack F. Shern, Jack Collins, Javed Khan

Summary: This study utilized convolutional neural networks (CNN) to predict high-risk mutations and prognosis of rhabdomyosarcoma (RMS) based on histologic features learned from H&E images. The CNN model achieved superior performance in predicting survival and event-free outcomes compared to current molecular-clinical risk stratification methods.

CLINICAL CANCER RESEARCH (2023)

Article Cell Biology

Centrosome amplification promotes cell invasion via cell-cell contact disruption and Rap-1 activation

Anu Prakash, Shishir Paunikar, Mark Webber, Emma Mcdermott, Sri H. Vellanki, Kerry Thompson, Peter Dockery, Hanne Jahns, James A. L. Brown, Ann M. Hopkins, Emer Bourke

Summary: This study investigates the mechanistic contributions of centrosome amplification (CA) induction alone to tumor architecture and extracellular matrix (ECM) remodeling. The results demonstrate that CA induction can lead to cell migration and invasion, disruption of epithelial cell-cell junction integrity, and dysregulation of cell junction proteins. Furthermore, CA induction increases the expression of integrin beta-3, fibronectin-1, and matrix metalloproteinase enzymes, promoting cell-ECM attachment, ECM degradation, and a migratory and invasive cell phenotype.

JOURNAL OF CELL SCIENCE (2023)

Meeting Abstract Surgery

SERUM JAM-A AS A PREDICTOR OF TREATMENT RESISTANCE IN BREAST CANCER PATIENTS

E. J. Rutherford, C. E. Richards, A. O. Leech, A. D. K. Hill, A. M. Hopkins

BRITISH JOURNAL OF SURGERY (2021)

Meeting Abstract Oncology

Junctional adhesion molecule-A (JAM-A) as a novel future drug target in ductal carcinoma in situ (DCIS)

Ann M. Hopkins, Yvonne E. Smith, Guannan Wang, Ciara Flynn, Alexander Casucci, Sri HariKrishna Vellanki, Lance Hudson, Kieran Brennan, Mattia Cremona, Saraswati Sukumar

CANCER RESEARCH (2020)

暂无数据